PANDA Therapeutics secures €160K to advance multi-target Alzheimer’s therapy
PANDA Therapeutics secures €160K to advance multi-target Alzheimer’s therapy Biotech startup PANDA Therapeutics has obtained €160,000 (CHF 150,000) from Venture Kick to advance a new treatment for Alzheimer’s disease toward clinical development. By targeting multiple harmful protein deposits in the brain with a single therapy, the startup aims to improve
